Magnetar Financial LLC Guardant Health, Inc. Transaction History

Magnetar Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $1.02 Million - $1.36 Million	-10,308 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$109.77 - $165.68 $1.13 Million - $1.71 Million	10,308 New	10,308 $1.28 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $827,697 - $1.15 Million	-10,305 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $623,349 - $1 Million	10,305 New	10,305 $836,000
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $450,593 - $677,797	-7,632 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$59.49 - $82.78 $279,484 - $388,900	-4,698 Reduced 38.1%	7,632 $596,000
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $458,784 - $808,499	7,330 Added 146.6%	12,330 $787,000
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $319,700 - $455,550	5,000 New	5,000 $432,000
Q1 2019 May 15, 2019	SELL	$34.3 - $97.98 $706,579 - $2.02 Million	-20,600 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $601,520 - $949,660	20,600 New	20,600 $774,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.